Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial.
Ripa M, Pogliaghi M, Chiappetta S, Galli L, Pensieroso S, Cavarelli M, Scarlatti G, De Biasi S, Cossarizza A, De Battista D, Malnati M, Lazzarin A, Nozza S, Tambussi G. Ripa M, et al. Among authors: scarlatti g. Clin Microbiol Infect. 2015 Sep;21(9):876.e1-4. doi: 10.1016/j.cmi.2015.05.007. Epub 2015 May 14. Clin Microbiol Infect. 2015. PMID: 25980351 Free article. Clinical Trial.
Prognostic significance of immunologic changes in 675 infants perinatally exposed to human immunodeficiency virus. The Italian Register for Human Immunodeficiency Virus Infection in Children.
de Martino M, Tovo PA, Galli L, Gabiano C, Cozzani S, Gotta C, Scarlatti G, Fiocchi A, Cocchi P, Marchisio P, et al. de Martino M, et al. Among authors: scarlatti g. J Pediatr. 1991 Nov;119(5):702-9. doi: 10.1016/s0022-3476(05)80283-5. J Pediatr. 1991. PMID: 1682435 Clinical Trial.
Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele.
Furci L, Scarlatti G, Burastero S, Tambussi G, Colognesi C, Quillent C, Longhi R, Loverro P, Borgonovo B, Gaffi D, Carrow E, Malnati M, Lusso P, Siccardi AG, Lazzarin A, Beretta A. Furci L, et al. Among authors: scarlatti g. J Exp Med. 1997 Aug 4;186(3):455-60. doi: 10.1084/jem.186.3.455. J Exp Med. 1997. PMID: 9236198 Free PMC article.
Oral CCR5 inhibitors: will they make it through?
Biswas P, Nozza S, Scarlatti G, Lazzarin A, Tambussi G. Biswas P, et al. Among authors: scarlatti g. Expert Opin Investig Drugs. 2006 May;15(5):451-64. doi: 10.1517/13543784.15.5.451. Expert Opin Investig Drugs. 2006. PMID: 16634684 Review.
145 results